Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology


  1. Accepted/In press

    “One more chance to survive”: the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy—a qualitative study and recommendations for future care

    Egeler, M. D., Boomstra, E., Rohaan, M. W., Van den Heuvel, N. M. J., Fraterman, I., Delfos, M., van de Poll-Franse, L. V., Borch, T. H., Svane, Inge Marie, Haanen, J. B. A. G., Retèl, V. P. & Boekhout, A. H., 2024, (Accepted/In press) In: Journal of Cancer Survivorship.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma

    Borch, T. H., Engell-Noerregaard, L., Iversen, T. Z., Ellebaek, E., Met, Özcan, Hansen, M., Andersen, Mads Hald, thor Straten, E. P. & Svane, Inge Marie, 1 Sep 2016, In: OncoImmunology. 5, 9, 12 p., e1207842.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Wildtype p53-specific Antibody and T-Cell Responses in Cancer Patients

    Pedersen, Anders Elm, Stryhn, A., Justesen, S., Harndahl, M., Rasmussen, S., Donskov, F., Claesson, Mogens Helweg, Pedersen, J. W., Wandall, Hans H., Svane, Inge Marie & Buus, Søren, 2011, In: Journal of Immunotherapy. 34, 9, p. 629-40 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

    Trepiakas, R., Berntsen, A., Hadrup, S. R., Bjørn, J., Geertsen, P. F., Straten, P. T., Andersen, Mads Hald, Pedersen, Anders Elm, Soleimani, A., Lorentzen, T., Johansen, Julia Sidenius & Svane, Inge Marie, 1 Oct 2010, In: Cytotherapy. 12, 6, p. 721-34 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Vaccination against pd-l1 with io103 a novel immune modulatory vaccine in basal cell carcinoma: A phase iia study

    Jørgensen, N. G., Kaae, Jeanette, Grauslund, J. H., Met, Özcan, Nielsen, S. L., Pedersen, A. W., Svane, Inge Marie, Ehrnrooth, E., Andersen, Mads Hald, Zachariae, Claus & Skov, Lone, 2021, In: Cancers. 13, 4, p. 1-15 15 p., 911.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Uncoupling CD4þ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

    Draghi, A., Presti, M., Jensen, A. W. P., Chamberlain, C. A., Albieri, B., Rasmussen, A. C. K., Andersen, M. H., Crowther, M. D., Svane, Inge Marie & Donia, M., 1 Oct 2023, In: Clinical Cancer Research. 29, 19, p. 3937-3947 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

    Westergaard, M. C. W., Andersen, R., Chong, C., Kjeldsen, J. W., Pedersen, M., Friese, C., Hasselager, T., Lajer, H., Coukos, G., Bassani-Sternberg, M., dqp123, dqp123 & Svane, Inge Marie, 2019, In: British Journal of Cancer. 120, p. 424-434

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Tumor-infiltrating lymphocytes for the treatment of metastatic cancer

    Geukes Foppen, M. H., Donia, M., Svane, Inge Marie & Haanen, J. B. A. G., Dec 2015, In: Molecular Oncology. 9, 10, p. 1918-35 18 p.

    Research output: Contribution to journalReviewResearchpeer-review

  9. Published

    Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions

    Granhøj, J. S., Jensen, Agnete Witness Præst, Presti, M., Met, Özcan, Svane, Inge Marie & dqp123, dqp123, 2022, In: Expert Opinion on Biological Therapy. 22, 5, p. 627-641 15 p.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations

    Hansen, U. K., Ramskov, S., Bjerregaard, A. M., Borch, A., Andersen, R., Draghi, A., dqp123, dqp123, Bentzen, A. K., Marquard, A. M., Szallasi, Z., Eklund, A. C., Svane, Inge Marie & Hadrup, S. R., 2020, In: Frontiers in Immunology. 11, 373.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...28 Next

ID: 4054758